Optical properties of cometary particles collected by the COSIMA mass spectrometer on-board <i>Rosetta</i> during the rendezvous phase around comet 67P/Churyumov–Gerasimenko

40 000 collected cometary particles have been identified on the 21 targets exposed by the COSIMA experiment on-board Rosetta to the environment of comet 67P/Churyumov–Gerasimenko from 2014 August to 2016 September. The images of the targets where obtained by the COSIMA microscope (Cosiscope, 13.95 μm pixel−1) with near grazing incidence, which is optimal for the primary objective (detection of collected particles) but very challenging for photometry. However, more than 300 of the collected particles are larger than 100 μm which makes it possible to derive constraints on the optical properties from the distribution of light levels within the particles. Two types of particles collected by COSIMA (compact particles and cluster particles) have been identified in Langevin et al. The best estimate reflectance factors of compact particles range from 10 per cent to 23 per cent. For cluster particles (>90 per cent of large collected particles), the comparison of the signal profiles with illumination from two opposite directions shows that there is scattering within the particles, with a mean free path in the 20–25 μm range, which requires high porosity. The best estimate reflectance factors of cluster particles range from 3 per cent to 22 per cent. This range of reflectance factors overlaps with that obtained from observations of the cometary nucleus at macroscopic scales by OSIRIS and it is consistent with that measured for interplanetary dust particles collected in the stratosphere of the Earth

Analysis of the course and treatment of toxocariasis in children—a long-term observation

Toxocariasis is a helminthozoonotic disease caused by ascarid larvae of Toxocara genus: Toxocara canis and Toxocara cati. In the reported study, the clinical course of toxocariasis and administered therapy were evaluated in 103 children. The majority of the children (68.9%) were from the rural environment, with a prevalence of boys (62.1%). At diagnosis of infection, 36 (35%) children reported recurrent abdominal pain, 19 (18.4%) headache, 6 (5.8%) loss of appetite, 2 subfebrile conditions, and 2 arthralgia, Moreover, 23 (22.3%) children demonstrated symptoms of atopic diseases; in 30 (29.1%) children, moderate enlargement of lymphatic nodes was noted. In five children (4.9%), ophthalmic examination revealed unilateral changes in the eye: in two cases retinitis; in one case fibrotic lesions in the vitreous body, complicated 1 year from diagnosis by retinal detachment; and in other children parafoveal lesions and cataract. Only two children with ocular changes at diagnosis reported visual disorders. In 64.3% of children, eosinophilia was observed. A covert form of the disease was diagnosed in 95.1% of the children and an ocular form in 4.9%. In all the children, antiparasitic treatment was implemented, repeated several times in some of them. After therapy, the mean titer of specific antibodies, the number of children with abdominal pains and enlarged lymphatic nodes were decreased, while headaches maintained at unchanged levels. In approximately one fourth of the children with negative results of antibodies after the therapy, the symptoms of the disease were still reported. Evaluation of the efficacy of treatment is not easy due to non-characteristic symptoms and low kinetics of specific anti Toxocara IgG decrease; however, high IgG titers suggest non-effective treatment of concomitant infection requiring subsequent therapy. Due to risk of ocular form, which may develop in any stage of the disease, irrespectively of specific antibodies concentrations, it seems justified to implement antiparasitic treatment in all children infected with T. canis

Surface composition and properties of Ganymede: Updates from ground-based observations with the near-infrared imaging spectrometer SINFONI/VLT/ESO

Ganymede's surface exhibits great geological diversity, with old dark terrains, expressed through the surface composition, which is known to be dominated by two constituents: H2O-ice and an unidentified darkening agent. In this paper, new investigations of the composition of Ganymede's surface at global scale are presented. The analyses are derived from the linear spectral modeling of a high spectral resolution dataset, acquired with the near-infrared (1.40–2.50 μm) ground-based integral field spectrometer SINFONI (SINgle Faint Object Near-IR Investigation) of the Very Large Telescope (VLT hereafter) located in Chile. We show that, unlike the neighboring moon Europa, photometric corrections cannot be performed using a simple Lambertian model. However, we find that the Oren-Nayar (1994) model, generalizing the Lambert's law for rough surfaces, produces excellent results. Spectral modeling confirms that Ganymede's surface composition is dominated by H2O-ice, which is predominantly crystalline, as well as a darkening agent, but it also clearly highlights the necessity of secondary species to better fit the measurements: sulfuric acid hydrate and salts, likely sulfates and chlorinated. A latitudinal gradient and a hemispherical dichotomy are the strongest spatial patterns observed for the darkening agent, the H2O-ice, and the sulfuric acid: the darkening agent is by far the major compound at the equator and mid-latitudes (≤ ± 35°N), especially on the trailing hemisphere, while the H2O-ice and the sulfuric acid are mostly located at high latitudes and on the leading hemisphere. This anti-correlation is likely a consequence of the bombardment of the constituents in the Jovian magnetosphere which are much more intense at latitudes higher than ±35°N. Furthermore, the modeling confirms that polar caps are enriched in small, fresh, H2O-ice grains (i.e. ≤50 μm) while equatorial regions are mostly composed of larger grains (i.e. ≥200 μm, up to 1 mm). Finally, the spatial distribution of the salts is neither related to the Jovian magnetospheric bombardment nor the craters. These species are mostly detected on bright grooved terrains surrounding darker areas. Endogenous processes, such as freezing of upwelling fluids going through the ice shell, may explain this distribution. In addition, a small spectral residue that might be related to brines and/or hydrated silica-bearing minerals are located in the same areas

Optical properties of cometary particles collected by the COSIMA mass spectrometer on-board Rosetta during the rendezvous phase around comet 67P/Churyumov–Gerasimenko

40 000 collected cometary particles have been identified on the 21 targets exposed by the COSIMA experiment on-board Rosetta to the environment of comet 67P/Churyumov–Gerasimenko from 2014 August to 2016 September. The images of the targets where obtained by the COSIMA microscope (Cosiscope, 13.95 μm pixel−1) with near grazing incidence, which is optimal for the primary objective (detection of collected particles) but very challenging for photometry. However, more than 300 of the collected particles are larger than 100 μm which makes it possible to derive constraints on the optical properties from the distribution of light levels within the particles. Two types of particles collected by COSIMA (compact particles and cluster particles) have been identified in Langevin et al. The best estimate reflectance factors of compact particles range from 10 per cent to 23 per cent. For cluster particles (>90 per cent of large collected particles), the comparison of the signal profiles with illumination from two opposite directions shows that there is scattering within the particles, with a mean free path in the 20–25 μm range, which requires high porosity. The best estimate reflectance factors of cluster particles range from 3 per cent to 22 per cent. This range of reflectance factors overlaps with that obtained from observations of the cometary nucleus at macroscopic scales by OSIRIS and it is consistent with that measured for interplanetary dust particles collected in the stratosphere of the Earth.</p

BMC Cancer

Background: The exhaustive collection of new sarcoma cases and their second histologic review offer a unique opportunity to study their incidence and time trends in France according to the major subtypes. Methods: Data were collected from population-based cancer registries covering 22% of the French population. Crude and world age-standardized incidence rates (ASR) were estimated according to anatomic, histological and genetic groups, age and sex over the 2010–2013 period. Results: Time trends in incidence were calculated by the annual percent change over the 2000–2013 period. During the most recent period (2010–2013), 3942 patients with sarcoma were included. The ASR of soft-tissue and bone sarcomas, and gastro-intestinal stromal tumors (GIST) were 2.1, 1.0 and 0.6, respectively. For the four most frequent histological subtypes (unclassified, leiomyosarcoma, GIST and liposarcoma), the ASR ranged from 0.4 to 0.7. ASRs were 1.9 for complex genomic and 1.3 for recurrent translocation sarcomas. The time-trend analysis showed a significant increase of sarcoma incidence rate between 2000 and 2005, which stabilized thereafter. Incidence rates increased for four histological subtypes (GIST, chondrosarcoma, myxofibrosarcoma, solitary fibrous tumors) and decreased for three (leiomyosarcomas, Kaposi sarcoma and fibrosarcoma). Conclusion: To our knowledge, this study is the first to investigate sarcoma incidence based on a systematic pathological review of these cancers and on the updated sarcoma classifications. Due to the paucity of literature on sarcomas, future studies using data from population-based cancer registries should consider a standardized inclusion criterion presented in our study to better describe and compare data between countries

Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis

<p>Abstract</p> <p>Background</p> <p>Levels of pentosidine (representative of advanced glycation end-products) in sera of patients with rheumatoid arthritis are increased when compared with sera of other diagnoses or healthy controls. These levels have been reported to correlate with clinical indices of rheumatoid arthritis activity and with laboratory markers of inflammation. The purpose of this study was to find out if these findings pertain to other advanced glycation end-products.</p> <p>Methods</p> <p>We have developed two immunoassays based on new monoclonal antibodies to advanced glycation end-products. Antibody 103-E3 reacts with an unidentified antigen, formed in the reaction of proteins with ribose, while antibody 8-C1 responds to N^ε-(carboxyethyl)lysine. We have used these monoclonal antibodies to measure levels of advanced glycation end-products in sera of patients with rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and healthy controls. We calculated the correlations between advanced glycation end-product levels in rheumatoid arthritis sera and the Disease Activity Score 28 (DAS28), age, disease duration, CRP, anti-CCP, rheumatoid factor and treatment with corticosteroids, respectively.</p> <p>Results</p> <p>Levels of both glycation products were significantly higher in sera of patients with rheumatoid arthritis when compared with sera of patients with systemic lupus erythematosus, osteoarthritis, or the healthy controls. Neither the level of N^ε-(carboxyethyl)lysine nor the level of the 103-E3 antigen in rheumatoid arthritis sera correlated with the DAS28-scored rheumatoid arthritis activity. The levels of both antigens in rheumatoid arthritis sera did not correlate with age, gender, corticosteroid treatment, or levels of CRP, anti-CCP antibodies, and rheumatoid factor in sera.</p> <p>Conclusions</p> <p>We report highly specific increases in the levels of two advanced glycation end-products in sera of patients with rheumatoid arthritis. This increase could be explained neither by rheumatoid arthritis activity nor by inflammation. We propose a working hypothesis that presumes the existence of a link between advanced glycation end-product formation and induction of autoimmunity.</p

Toxocariasis: a silent threat with a progressive public health impact

Background: Toxocariasis is a neglected parasitic zoonosis that afflicts millions of the pediatric and adolescent populations worldwide, especially in impoverished communities. This disease is caused by infection with the larvae of Toxocara canis and T. cati, the most ubiquitous intestinal nematode parasite in dogs and cats, respectively. In this article, recent advances in the epidemiology, clinical presentation, diagnosis and pharmacotherapies that have been used in the treatment of toxocariasis are reviewed. Main text: Over the past two decades, we have come far in our understanding of the biology and epidemiology of toxocariasis. However, lack of laboratory infrastructure in some countries, lack of uniform case definitions and limited surveillance infrastructure are some of the challenges that hindered the estimation of global disease burden. Toxocariasis encompasses four clinical forms: visceral, ocular, covert and neural. Incorrect or misdiagnosis of any of these disabling conditions can result in severe health consequences and considerable medical care spending. Fortunately, multiple diagnostic modalities are available, which if effectively used together with the administration of appropriate pharmacologic therapies, can minimize any unnecessary patient morbidity. Conclusions: Although progress has been made in the management of toxocariasis patients, there remains much work to be done. Implementation of new technologies and better understanding of the pathogenesis of toxocariasis can identify new diagnostic biomarkers, which may help in increasing diagnostic accuracy. Also, further clinical research breakthroughs are needed to develop better ways to effectively control and prevent this serious disease